2023 - Research.com Medicine in Sweden Leader Award
Göran Berglund focuses on Internal medicine, Risk factor, Prospective cohort study, European Prospective Investigation into Cancer and Nutrition and Endocrinology. Blood pressure is the focus of his Internal medicine research. His Risk factor study also includes
As part of the same scientific family, Göran Berglund usually focuses on Prospective cohort study, concentrating on Myocardial infarction and intersecting with C-reactive protein. His research integrates issues of Hazard ratio, Colorectal cancer and Environmental health in his study of European Prospective Investigation into Cancer and Nutrition. He has included themes like Odds ratio, Single-nucleotide polymorphism and Oncology in his Endocrinology study.
Internal medicine, Endocrinology, Risk factor, Blood pressure and Prospective cohort study are his primary areas of study. His Internal medicine research incorporates elements of Surgery, Oncology and Cardiology. His work deals with themes such as Incidence, Epidemiology, Cohort study, Relative risk and Cohort, which intersect with Risk factor.
His Blood pressure research is multidisciplinary, incorporating perspectives in Stroke and Hemodynamics. The study incorporates disciplines such as Odds ratio and Case-control study in addition to Prospective cohort study. The concepts of his European Prospective Investigation into Cancer and Nutrition study are interwoven with issues in Environmental health, Gastroenterology, Stomach cancer, Hazard ratio and Colorectal cancer.
His primary areas of investigation include Internal medicine, Endocrinology, Blood pressure, Cardiology and Essential hypertension. In his study, Epidemiology is strongly linked to Surgery, which falls under the umbrella field of Internal medicine. His biological study deals with issues like Pharmacology, which deal with fields such as Practolol and Propranolol.
His study on Blood pressure also encompasses disciplines like
His primary areas of study are Internal medicine, Endocrinology, Blood pressure, Risk factor and Genetics. His research on Internal medicine often connects related areas such as Diabetes mellitus. In his research, Vasopressin is intimately related to C-reactive protein, which falls under the overarching field of Endocrinology.
His work carried out in the field of Blood pressure brings together such families of science as Diuretic and Cardiology. His studies examine the connections between Risk factor and genetics, as well as such issues in Cohort, with regards to Gastroenterology, Incidence, Clinical nutrition, Metabolic syndrome and Anthropometry. His work in Cohort study tackles topics such as Prospective cohort study which are related to areas like Omics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
European prospective investigation into cancer and nutrition (EPIC): study populations and data collection
E. Riboli;K. J. Hunt;N. Slimani;P. Ferrari.
Public Health Nutrition (2002)
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.
Sekar Kathiresan;Sekar Kathiresan;Olle Melander;Candace Guiducci;Aarti Surti.
Nature Genetics (2008)
Genome-wide association study identifies eight loci associated with blood pressure
Christopher Newton-Cheh;Christopher Newton-Cheh;Toby Johnson;Toby Johnson;Vesela Gateva;Martin D. Tobin.
Nature Genetics (2009)
Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study
Sheila A Bingham;Nicholas E Day;Robert Luben;Pietro Ferrari.
The Lancet (2003)
Meat, Fish, and Colorectal Cancer Risk: The European Prospective Investigation into Cancer and Nutrition
Teresa Norat;Sheila Bingham;Pietro Ferrari;Nadia Slimani.
Journal of the National Cancer Institute (2005)
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.
Sekar Kathiresan;Benjamin F Voight;Shaun Purcell;Kiran Musunuru.
Nature Genetics (2009)
Clinical risk factors, DNA variants, and the development of type 2 diabetes.
Valeriya Lyssenko;Anna Jonsson;Peter Almgren;Nicoló Pulizzi.
The New England Journal of Medicine (2008)
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
Valeriya Lyssenko;Roberto Lupi;Piero Marchetti;Silvia Del Guerra.
Journal of Clinical Investigation (2007)
Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study
Antonia Trichopoulou;Philippos Orfanos;Teresa Norat;Bas Bueno-de-Mesquita.
BMJ (2005)
Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events
Sekar Kathiresan;Olle Melander;Dragi Anevski;Candace Guiducci.
The New England Journal of Medicine (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Imperial College London
Aarhus University
Imperial College London
Lund University
University of Copenhagen
German Institute of Human Nutrition
University of Cambridge
Provincial Health Authority of Syracuse
University of Naples Federico II
Utrecht University
Institute for the Study and Prevention of Cancer (Istituto per lo Studio, la Prevenzione e la Rete Oncologica)
Publications: 430
University of New South Wales
Hong Kong Polytechnic University
Technical University of Munich
Polytechnic University of Milan
Peking University
University of Massachusetts Medical School
Agricultural Research Service
University of Gothenburg
University of Münster
University of Cambridge
University of Guelph
Agricultural Research Service
University of Minnesota
Université Laval
Goethe University Frankfurt
University of Minnesota